These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20573508)

  • 1. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
    Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
    Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
    Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
    J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.
    Fox A; Kaur S; Li B; Panesar M; Saha U; Davis C; Dragoni I; Colley S; Ritchie T; Bevan S; Burgess G; McIntyre P
    Br J Pharmacol; 2005 Apr; 144(7):889-99. PubMed ID: 15685199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
    Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
    J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
    Cole AG; Metzger A; Brescia MR; Qin LY; Appell KC; Brain CT; Hallett A; Ganju P; Denholm AA; Wareing JR; Ritchie TJ; Drake GM; Bevan SJ; MacGloinn A; McBryde A; Patel V; Oakley PJ; Nunez X; Gstach H; Schneider P; Baldwin JJ; Dolle RE; McDonald E; Henderson I
    Bioorg Med Chem Lett; 2009 Jan; 19(1):119-22. PubMed ID: 19014884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.
    Campos MM; Leal PC; Yunes RA; Calixto JB
    Trends Pharmacol Sci; 2006 Dec; 27(12):646-51. PubMed ID: 17056130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
    Chen JJ; Nguyen T; D'Amico DC; Qian W; Human J; Aya T; Biswas K; Fotsch C; Han N; Liu Q; Nishimura N; Peterkin TA; Yang K; Zhu J; Riahi BB; Hungate RW; Andersen NG; Colyer JT; Faul MM; Kamassah A; Wang J; Jona J; Kumar G; Johnson E; Askew BC
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3384-9. PubMed ID: 21514825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
    Huang H; Player MR
    J Med Chem; 2010 Aug; 53(15):5383-99. PubMed ID: 20369879
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.
    Ritchie TJ; Dziadulewicz EK; Culshaw AJ; Müller W; Burgess GM; Bloomfield GC; Drake GS; Dunstan AR; Beattie D; Hughes GA; Ganju P; McIntyre P; Bevan SJ; Davis C; Yaqoob M
    J Med Chem; 2004 Sep; 47(19):4642-4. PubMed ID: 15341478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
    Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
    J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.
    Schaudt M; Locardi E; Zischinsky G; Stragies R; Pfeifer JR; Gibson C; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1225-8. PubMed ID: 20015645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.
    Schnatbaum K; Schaudt M; Stragies R; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Zischinsky G
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1233-6. PubMed ID: 20036120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
    Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
    J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.